MoneyWorks4Me

Sanofi India - Quaterly Results

23 Feb 2022 Evaluate
The revenue for the December 2021 quarter is pegged at Rs. 6879.00 millions against Rs. 7203.00 millions recorded during the year-ago period.The Company's Net profit for the December 2021 quarter have declined marginally to Rs. 904.00  millions as against Rs. 1230.00 millions reported during the corresponding quarter ended.Operating profit for the quarter ended December 2021 decreased to 1435.00 millions as compared to 1832.00 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202112 202012 % Var
Sales 6879.00 7203.00 -4.50 29566.00 29019.00 1.88 29566.00 29019.00 1.88
Other Income 163.00 162.00 0.62 744.00 898.00 -17.15 744.00 898.00 -17.15
PBIDT 1435.00 1832.00 -21.67 8369.00 8029.00 4.23 8369.00 8029.00 4.23
Interest 4.00 4.00 0.00 18.00 18.00 0.00 18.00 18.00 0.00
PBDT 1431.00 1906.00 -24.92 13243.00 7594.00 74.39 13243.00 7594.00 74.39
Depreciation 109.00 204.00 -46.57 667.00 822.00 -18.86 667.00 822.00 -18.86
PBT 1322.00 1702.00 -22.33 12576.00 6772.00 85.71 12576.00 6772.00 85.71
TAX 418.00 472.00 -11.44 3132.00 1996.00 56.91 3132.00 1996.00 56.91
Deferred Tax -12.00 5.00 -340.00 -228.00 -114.00 100.00 -228.00 -114.00 100.00
PAT 904.00 1230.00 -26.50 9444.00 4776.00 97.74 9444.00 4776.00 97.74
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 20.86 25.43 -17.98 28.31 27.67 2.31 28.31 27.67 2.31
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..